Clinical Trials Logo

Clinical Trial Summary

The investigators conduct a randomized, double-blind, placebo-controlled study to investigate the effects of the SCE on muscle strength, muscle mass, and muscle function in healthy adults for 12 weeks.


Clinical Trial Description

Previous studies have indicated that Schisandra chinensis extract (SCE) may have the ability to prevent skeletal muscle atrophy. Therefore, the investigators conduct a randomized, double-blind, placebo-controlled study to investigate the effects of the SCE on muscle strength, muscle mass, and muscle function in healthy adults; the safety of the compound are also evaluate. The Investigators examine the peak torque/body weight at 60°/s knee extension, handgrip strength, skeletal muscle mass, physical performance, and metabolic parameters at baseline, as well as after 4 and 12 weeks of intervention. Fifty-four healthy adults were administered either 1,000 mg of SCE or a placebo each day for 12 weeks; ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03402308
Study type Interventional
Source Pusan National University Yangsan Hospital
Contact
Status Completed
Phase N/A
Start date June 1, 2017
Completion date March 1, 2018

See also
  Status Clinical Trial Phase
Completed NCT04109911 - Effect of Fermented Oyster Extract on Musculoskeletal Biomarkers in Relative Sarcopenia Adults N/A
Completed NCT04320121 - Effect of Nelutriā„¢ on Musculoskeletal Biomarkers in Relative Sarcopenia Adults N/A